These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10566077)

  • 1. Prophylactic HIV vaccines. Summary and table.
    Wagstaff A; Brooke G
    Drugs R D; 1999 Jun; 1(6):441-3. PubMed ID: 10566077
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV gp160 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern).
    Drugs R D; 1999 Jun; 1(6):451-2. PubMed ID: 10566081
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV vaccine vCP205. ALVAC-HIV vCP205, ALVAC vCP205.
    Drugs R D; 1999 Jun; 1(6):459-60. PubMed ID: 10566084
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV gp120 vaccine (Chiron).
    Drugs R D; 1999 Jun; 1(6):445-7. PubMed ID: 10566078
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV gp160 vaccine (Immuno AG).
    Drugs R D; 1999 Jun; 1(6):449-50. PubMed ID: 10566080
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV gp120 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern).
    Drugs R D; 1999 Jun; 1(6):448. PubMed ID: 10566079
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS clinical trials at John Hopkins.
    Hopkins HIV Rep; 2000 Jan; 12(1):suppl 1-4. PubMed ID: 11366319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus: scientific challenges impeding candidate vaccines.
    Idemyor V
    HIV Clin Trials; 2003; 4(6):421-4. PubMed ID: 14628286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDSVAX VaxGen.
    Billich A
    Curr Opin Investig Drugs; 2004 Feb; 5(2):214-21. PubMed ID: 15043397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Philadelphia area AIDS/HIV clinical trials.
    Crit Path AIDS Proj; 1998; (No 33):35-43. PubMed ID: 11366372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design and testing of HIV prophylactic vaccines.
    Ada G
    AIDS Res Hum Retroviruses; 1992 May; 8(5):758-63. PubMed ID: 1515227
    [No Abstract]   [Full Text] [Related]  

  • 12. Can HIV infection be prevented with a vaccine?
    Joy AK; Dale CJ; Kent SJ
    Drugs R D; 1999 Jun; 1(6):431-40. PubMed ID: 10566076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines.
    Ferrantelli F; Cafaro A; Ensoli B
    Curr Opin Biotechnol; 2004 Dec; 15(6):543-56. PubMed ID: 15560981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perspectives for the development of preventive vaccines against HIV/AIDS].
    Esparza J
    Medicina (B Aires); 1998; 58 Suppl 1():57-63. PubMed ID: 9674249
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA vaccination for HIV-1 and SIV.
    Barouch DH; Letvin NL
    Intervirology; 2000; 43(4-6):282-7. PubMed ID: 11251383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the development of HIV vaccines.
    Girard MP; Eichberg JW
    AIDS; 1990; 4 Suppl 1():S143-50. PubMed ID: 2152559
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for control of HIV infections.
    Sharma KB
    J Indian Med Assoc; 1994 Jan; 92(1):27-8. PubMed ID: 8207277
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies.
    Chin'ombe N; Ruhanya V
    Pan Afr Med J; 2015; 20():386. PubMed ID: 26185576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS 1995. Vaccines and immunology: overview.
    Montelaro RC; Wigzell H
    AIDS; 1995; 9 Suppl A():S111-2. PubMed ID: 8819577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.